Products

What will AGI do for Ambroxol?

This classification denotes a mucolytic agent and expectorant with the molecular formula C13H18Br2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 200168S0CL, chemically known as trans-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanol but more generally known as ambroxol, which bears US NIH Compound Identifier 2132. Ambroxol most often comes in base and hydrochloride forms. European Medicines Agency schedules Ambroxol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05397MIG. The term AMBROXOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules ambroxol in its Anatomical Therapeutic Chemical (ATC) Classification. AMBROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ambroxol under HS 29221980 and SITC 51461. As of Q4 2014, AMBROXOL remains US FDA's Preferred Term for this commodity. Ambroxol bears US NLM identifiers UMLS ID C0002421 and NCI Concept Code C74262. SMILES: BRC1C(N)C(CNC2CCC(O)CC2)CC(BR)C1.